Neuralytix, LLC (www.nerve.health) today announced full commercial availability of its iD3 System, an FDA 510(k)-cleared mechanomyography (MMG) platform that gives spine surgeons real-time, objective feedback on neurophysiologic changes occurring throughout decompression surgery. The launch builds on the system's initial commercial release in October 2025 and is now available through Neuralytix' U.S. distributor network. The iD3 System is surgeon-directed and requires no ded

Onkos Surgical, a leader in innovative solutions for musculoskeletal oncology and complex orthopaedic conditions, today announced the completion of the 1,000th case utilizing its personalized, 510(k) cleared, My3D® patient-specific pelvic implant platform. The milestone reflects the impact of innovative 3D printing technology and personalized approaches to orthopaedic cases where anatomy, bone loss, tumor involvement, and revision history benefit from an individualized approach.

CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell” or the “Company”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for two new AI algorithm enhancements integrated directly into its existing cloud-based Neurology Portal: Epileptiform Abnormality Detection and Artifact Reduction.1 These new capabilities expand the clinica

Kardium Inc., a private medical device company that’s advancing the way the world treats atrial fibrillation (AF), announced today that Health Canada has granted a Medical Device Licence for the Globe® Pulsed Field System. Building on the successful U.S. launch of the Globe System following FDA approval in 2025, Health Canada approval marks the next major milestone in expanding access to Kardium’s integrated mapping and pulsed field ablation platform. Developed in Ca

Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative interventional technologies intended to transform eye care and improve patients' lives, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the OMNI® Ultra Surgical System (OMNI Ultra) for canaloplasty followed by trabeculotomy for the reduction of intraocular pressure (IOP) in adult patients with primary open-angle glaucoma (POAG).

 SOPHiA GENETICS (NASDAQ: SOPH) today announced a new global collaboration to develop, validate, and deploy two companion diagnostics (CDx) supporting precision oncology therapies with AstraZeneca (LSE/STO/NYSE: AZN). This multi-year collaboration agreement will advance the development and commercialization of two companion diagnostic programs, bringing SOPHiA GENETICS's decentralized clinical trial assays and companion diagnostic capabilities to AstraZeneca therapies. 

Bookmark Medical today announced the completion of its acquisition of Village Medical Michigan, marking the organization's entry into Michigan and expanding its provider-led care network to four states. Effective Aug. 3, 2026, the acquisition brings seven primary care practices, a diagnostic center and Huron Valley Practice Affiliates (HVPA), an independent physician organization, into the Bookmark Medical network. The acquisition includes approximately 40 providers, more than 3

InterSystems, a creative data technology provider powering more than one billion health records globally, today announced the successful deployment of InterSystems TrakCare® across iKang Outpatient，the premium healthcare services brand of iKang Healthcare Group. The TrakCare deployment establishes a unified electronic health record (EHR) solution, resolving issues such as data

Median Technologies manufacturer of eyonis®, a suite of artificial intelligence (AI) powered Software as Medical Devices (SaMD) for the early detection and diagnosis of cancers, and a globally leading provider of AI-based image analyses and central imaging services for oncology drug developers, today announced the signing of a strategic commercial partnership with Canon Medical Systems Corporation through Canon’s subsidiary Olea Medical, marking an important new step in the executio

The MolinaCares Accord (“MolinaCares”), in collaboration with Molina Healthcare of Indiana (“Molina”), announced a $150,000 grant to Indy Reads to develop new curricula that help adult students better understand healthcare — from talking to doctors, to managing health conditions, to encouraging individuals to take an active role in improving their health. People who understand their health information are more likely to follow their treatment plans and